Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results

Go back to Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results
(NASDAQ: CRVS) Delayed: 12.68 +0.45 (3.68%)
Previous Close $12.23    52 Week High $17.77 
Open $12.55    52 Week Low $9.63 
Day High $12.69    P/E N/A 
Day Low $12.43    EPS $0.00 
Volume 211,338